DIPG-32. PRECLINICAL TESTING OF THE EFFICACY AND SAFETY OF CRISPR/CAS9 GENE EDITED CAR-T CELL THERAPY FOR DIFFUSE MIDLINE GLIOMA (DMG)

por Balakrishnan, Ilango, Leach, Lillie, Pierce, Angela, Lakshmanachetty, Senthilnath, Madhavan, Krishna, Fosmire, Susan, Chatwin, Hannah, Green, Adam, Fry, Terry, Vibhakar, Rajeev, Kohler, Eric M, Venkataraman, Sujatha
Publicado 2023

IMMU-23. Novel gene-edited CAR-T cell therapy against Diffuse Intrinsic Pontine Glioma

por Balakrishnan, Ilango, Leach, Lillie, Lakshmanachetty, Senthilnath, Pierce, Angela, Madhavan, Krishna, Chatwin, Hannah, Fosmire, Susan, Meadows, Christina, Green, Adam, Fry, Terry, Vibhakar, Rajeev, Kohler, Eric M, Venkataraman, Sujatha
Publicado 2022

Potent preclinical activity of FLT3-directed chimeric antigen receptor T-cell immunotherapy against FLT3-mutant acute myeloid leukemia and KMT2A-rearranged acute lymphoblastic leuk...

por Niswander, Lisa M., Graff, Zachary T., Chien, Christopher D., Chukinas, John A., Meadows, Christina A., Leach, Lillie C., Loftus, Joseph P., Kohler, M. Eric, Tasian, Sarah K., Fry, Terry J.
Publicado 2022